MAPS PrEP Van Study
ConditionHIV Infection
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorDuke University
About this trial
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Eligibility criteria
Qualifiers
18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program
Disqualifiers
positive HIV status
Trial design
Treatments tested in this trial
- Pre-Exposure Prophylaxis (PrEP)
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Duke University
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Source ClinicalTrials.gov